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Rapid, accurate, and quantitative characterization of immune status of patients is of utmost
importance for disease diagnosis and prognosis, evaluating efficacy of immunotherapeutics
and tailoring drug treatments. Immune status of patients is often dynamic and patient-
specific, and such complex heterogeneity has made accurate, real-time measurements
of patient immune status challenging in the clinical setting. Recent advances in microflu-
idics have demonstrated promising applications of the technology for immune monitoring
with minimum sample requirements and rapid functional immunophenotyping capability.
This review will highlight recent developments of microfluidic platforms that can perform
rapid and accurate cellular functional assays on patient immune cells. We will also discuss
the future potential of integrated microfluidics to perform rapid, accurate, and sensitive
cellular functional assays at a single-cell resolution on different types or subpopulations of
immune cells, to provide an unprecedented level of information depth on the distribution of
immune cell functionalities. We envision that such microfluidic immunophenotyping tools
will allow for comprehensive and systems-level immunomonitoring, unlocking the potential
to transform experimental clinical immunology into an information-rich science.
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INTRODUCTION
The immune status of patients with infectious diseases and
immune dysfunctions are dynamic and patient-specific, and such
complex heterogeneity has made immunomodulatory therapies
challenging in the clinic (Hotchkiss and Karl, 2003; Monneret
et al., 2008). An accurate and real-time measurement of the
immune status of patients is thus critical in disease diagnosis and
prognosis, evaluating efficacy of immunotherapeutics, and tailor-
ing drug treatments (Monneret et al., 2008). Functional cellular
immunophenotyping, which measures the functional status of
immune cells upon proliferation, cytolysis, and cytokine produc-
tion, is arguably among the best methods to determine immune
dysfunctions (Hotchkiss and Karl, 2003; Monneret et al., 2008; Lu
et al., 2013). Immune cells in blood constitute a complex, het-
erogeneous mixture of multiple cell types including granulocytes,
lymphocytes, and monocytes (Re and Strominger, 2004; Gordon
and Taylor, 2005; Kaech and Wherry, 2007; O’Shea et al., 2008).
The numbers, proportions, and cytolytic and cytokine production
activities of leukocyte subsets change drastically in the presence
of infections, malignancies, and autoimmune disorders (Revzin
et al., 2012). As such, there is a significant need for reliable tech-
nologies that can perform rapid and accurate functional cellular
immunophenotyping on patient immune cells and their subtypes
to define and characterize the “immune phenotype” of patients.
Several approaches currently exist for assessment of the
immune status of patients based on measuring cytokine produc-
tion of immune cells. Enzyme-linked immunosorbent assay/spot
(ELISA/ELISpot), for example, is a gold standard for quantifying
cellular cytokine production (Cox et al., 2006; Cornell et al., 2012).
ELISA/ELISpot has been commonly used for patients infected
by malaria (Aidoo and Udhayakumar, 2000), HIV (Kern et al.,
1999; Betts et al., 2000), and mycobacterium tuberculosis (Pathan
et al., 2000) and monitoring the immune response of cancer
patients undergoing immunotherapeutics (Janetzki et al., 2000;
Lewis et al., 2000). However, ELISA/ELISpot usually requires
numerous reagent manipulation processes that involve multiple
staining, washing, blocking, and sample transfer steps, which are
laborious and time-consuming. The complexity in implementing
ELISA/ELISpot has been prohibitive for standardization and their
utility in real-time clinical decision making. Further, ELISpot can-
not quantify the amount of cytokine secretion, and it requires
isolation and purification of desired subpopulations of immune
cells prior to analysis, necessitating extensive sample preparation
of blood specimens.
Functional cellular immunophenotyping can also be per-
formed using intracellular cytokine staining (ICS) flow cytom-
etry for single-cell cytokine production measurements with a
high-throughput (>103 cells/s) (Seder et al., 2008). However,
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ICS flow cytometry has so far only enabled detection of up
to five cytokines, providing only a partial picture of the func-
tional immune system. ICS flow cytometry also requires a large
number of cells in suspension (>1× 107 cells in 1 mL solution)
and is sample destructive, thus precluding downstream func-
tional assays that require live cells. ICS flow cytometry has so
far remained highly variable with regard to sample handling,
reagents, instrument setup, and data analysis, thus standard-
ization of ICS flow cytometry has been proved difficult if not
impossible.
The limitations associated with conventional approaches to
define the functional immune status of patients need to be fully
addressed to realize rapid and accurate analysis of immune phe-
notype of patients, a key step that provides crucial information
relating to staging, treatment choice, monitoring of efficacy, safety
and dose adjustment of immunomodulation, as well as biological
assessment of remission.
Recent advances in integrated microfluidics have made pos-
sible miniaturization and integration of biosample preparative
and analytical techniques on a single chip to enable rapid, sensi-
tive, and multiplexed high-throughput on-chip cell-based assays.
Some of these microfluidic tools have been demonstrated as
promising immune monitoring technologies with cell trapping
and analytic functionalities and a minimum sample requirement.
This review will highlight the recent development of microflu-
idic platforms that can perform rapid and accurate whole-blood
immunoassays of plasma components as well as functional cel-
lular immunophenotyping assays for quantitative analysis of
cytokine secretion properties of patient immune cells (Figure 1).
We will particularly discuss the future potential of integrated
microfluidics to perform rapid, accurate, and sensitive cellu-
lar functional assays at the single-cell resolution on immune
cell subpopulations isolated directly from patient blood, and
their potential to provide an unprecedented level of informa-
tion depth on the distribution of immune cell functionalities on a
patient-by-patient basis.
MICROFLUIDIC WHOLE-BLOOD IMMUNOASSAYS OF
PLASMA COMPONENTS
Whole-blood immunoassay is a most commonly used method
to examine patient immune status, which provides useful infor-
mation for diagnosis (Boomer et al., 2011; Cornell et al., 2012),
prognosis (Azizia et al., 2012), and deepening the biological under-
standing of immune and infectious diseases (Bernard et al., 2001;
Hotchkiss and Opal, 2010). Conventional whole-blood immune
tests are based on proteomic identification of biomarkers in
blood, relying on antibody-based heterogeneous or homogeneous
immunoassays (e.g., ELISA) to capture and recognize soluble
biomarkers in blood specimens. Recently, to achieve rapid on-
chip immunoassays with a minimum amount of blood, several
microfluidic whole-blood immunoassay devices have been devel-
oped. A notable example is the integrated blood barcode chip
reported by Fan et al. (2008) that can achieve on-chip plasma sepa-
ration from microliter quantities of whole-blood and rapid in situ
multiplexed protein biomarker measurements (Figure 2A). The
marked performance of the blood barcode chip comes from its two
integrated functional components: (1) a plasma-skimming chan-
nel that separates blood plasma based on the Zweifach–Fung effect;
(2) a protein detection region using a patterned DNA-encoded
antibody library (DEAL) barcode immobilized on the surface of
the plasma-skimming channel. Specifically, the DEAL technology
involves DNA-directed immobilization of antibodies to convert a
prepatterned ssDNA barcode microarray into an antibody array,
thus providing a powerful means for spatial encoding. The inte-
grated blood barcode chip and its recent improvement reported by
Wang et al. (2010) is capable of detecting picomolar concentrations
of cancer biomarkers and more than 10 cytokines simultaneously
from cancer patient blood.
MICROFLUIDIC WHOLE-BLOOD FUNCTIONAL
IMMUNOASSAYS
In addition to proteomic analysis for soluble biomarkers in blood
using microfluidic immunoassays, a recent exciting trend is to
FIGURE 1 | Schematic of functional immunophenotyping of immune cells.
Frontiers in Oncology | Tumor Immunity April 2013 | Volume 3 | Article 98 | 2
Chen et al. Emerging microfluidics for functional cellular immunophenotyping
FIGURE 2 | Integrated microfluidic devices for functional
immunophenotyping of immune cells in whole blood (A,B),
subpopulations of immune cells (C,D) and single immune cells (E,F).
(A) Design of the integrated blood barcode chip (IBBC). Adapted from Fan
et al. (2008), Copyright ©2008, with permission from Nature Publishing
Group. (B) Schematic of a multi-layered MIPA device consisting of a cell
culture chamber, a PDMS microfiltration membrane (PMM), and an
immunoassay chamber. Reproduced from Huang et al. (2012). (C)
Conceptual design of an antibody-coated microarray for detection of
cytokines secreted by CD4+ or CD8+T-cells. Reproduced from Zhu et al.
(2008) by permission of The Royal Society of Chemistry. (D) Schematic of
isolation and immunophenotyping of subpopulations of immune cells from
blood specimens by a combined use of both PMM and functionalized
microbeads. Reproduced from Chen et al. (2013). (E) Working principle of
the microengraving array for capture and immunomonitoring of single
immune cells. Adapted from Love et al. (2006), Copyright ©2006, with
permission from Nature Publishing Group. (F) Photograph and working
principle of the single-cell barcode chip for polycytokine analysis of single
immune cells. Adapted from Ma et al. (2011), Copyright ©2011, with
permission from Nature Publishing Group.
develop microfluidics-based cellular functional immune assays,
which is arguably a more direct measurement of the functional
status of immune cells. To achieve this, Huang et al. (2012)
have recently developed a microfluidic immunophenotyping assay
(MIPA) device for rapid and efficient on-chip isolation of periph-
eral blood mononuclear cells (PBMCs), their stimulation and cel-
lular cytokine secretion measurements (Figure 2B). A key compo-
nent of the MIPA device is a surface micromachined polydimethyl-
siloxane (PDMS) microfiltration membrane (PMM) for both iso-
lation of PBMCs from blood and allowing cytokines secreted from
lipopolysaccharide (LPS)-stimulated PBMCs to diffuse rapidly
into a biosensing chamber for quantitative immunosensing. The
MIPA device can achieve efficient on-chip cell isolation and
enrichment from blood owing to the high porosity of the PMM
as compared to existing polycarbonate filters (Vona et al., 2000;
Hofman et al., 2011) or parylene-based micropore membranes
(Zheng et al., 2011). For quantitative immunosensing, the MIPA
device utilizes a commercially available homogeneous chemilumi-
nescence technique, the “AlphaLISA,” which does not require any
washing or blocking step, greatly shortening the total assay time
and enhancing dynamic range for analyte detection. Owing to a
miniaturized on-chip microfluidic environment, the MIPA device
can achieve highly sensitive cellular immunophenotyping with 20-
fold fewer cells as compared to standard whole-blood stimulation
assay. The total assay time of the MIPA device using AlphaLISA
is seven times faster than that of whole-blood stimulation assay
using conventional ELISA.
Several microfluidics-based label-free, real-time detection tech-
niques have also been developed recently for immunosensing.
Development of real-time immunosensing techniques allows
detailed examination of the temporal dynamics of cytokine secre-
tion from immune cells, which may provide an informative and
unique signature about the functional status of patient immune
system (Revzin et al., 2012). The ability to assess dynamic cytokine
secretion from immune cells, for example, can allow detection
of the onset of the signaling process and study of intercellular
communications via cytokine-mediated paracrine and autocrine
signaling. Monitoring both the location and timing of cytokine
www.frontiersin.org April 2013 | Volume 3 | Article 98 | 3
Chen et al. Emerging microfluidics for functional cellular immunophenotyping
secretion events among a heterogeneous population of individual
immune cells can also determine which individual cells initiate the
immune response and which cells are then activated by such initial
immune response. In clinical diagnosis such as tuberculosis detec-
tion, pathogen biomarkers (e.g., pathogen-specific antibodies) are
not yet available. As such, cytokine production by T-cells is com-
monly used as a diagnostic marker for tuberculosis. If detection of
dynamic response of antigen-specific T cells becomes available, it
will enable early pathogen detection before pathogen biomarkers
are produced or the pathogen proliferates in the host.
A noteworthy microfluidic label-free immunodetection
method has been recently reported by Stern et al. (2007) based
on CMOS-compatible semiconducting nanowires for real-time
measurements of antibodies and early signals responsible for T-
cell activation. Another label-free biosensing technique reported
by Endo et al. (2008) has applied immobilized antibodies and
localized surface plasmon resonance (LSPR) to continuously mon-
itor concentration levels of cytokines secreted from mouse thy-
mus cells. The LSPR-based biosensor provides a promising plat-
form with attractive advantages of real-time detection of cellular
responses in a simplified experimental setup with a low sample
volume requirement. Overall, label-free cellular immunopheno-
typing permits real-time quantifications of dynamic cytokine
secretion, providing the unique functional signature of immune
cells such as how fast and strong immune cells secrete cytokines in
response to antigen stimulations.
MICROFLUIDIC IMMUNOPHENOTYPING OF
SUBPOPULATIONS OF IMMUNE CELLS
Microfluidic whole-blood immunoassays measure the overall
capacity of the whole population of leukocytes in blood to pro-
duce cytokines. Thus, microfluidic whole-blood immunoassays
may not be informative enough to accurately reveal the immune
status of patients, as in these “bulk” assays it is difficult to pinpoint
the phenotype or real identity of reactive immune cells involved.
Recently, there are great efforts from different research groups to
integrate cell separation techniques into microfluidic immunoas-
say devices and systems to achieve cellular functional analysis on
subpopulations of immune cells. Zhu et al. (2008) for example,
have recently developed a microarray device uniformly coated
with both T-cell capture antibodies (anti-CD4 and anti-CD8) and
cytokine capture antibodies (anti-IFN-γ and anti-IL-2) on top of a
poly(ethylene glycol) (PEG) hydrogel layer (Figure 2C). To enable
capturing and positioning of single CD4+ and CD8+ T-cells, the
antibody-coated microarray was covered with photolithographi-
cally patterned PEG hydrogel microwells on top of the antibody
containing hydrogel layer. The antibody-coated microarray can
directly process red blood cell (RBC) depleted human whole-blood
samples for capture of individual CD4+ and CD8+ T-cells and
subsequent functional examination of IFN-γ and IL-2 secretion
from single T-cells.
The antibody-based microarray platform reported by Zhu et
al. has simplified the sample preparation process and also reduced
the required volume of blood specimens. Although immobilized
antibodies offer a heightened cell isolation purity and cytokine
measurement sensitivity, it still suffers from several limitations,
including the need of multiple washing and blocking steps and
the difficulty to achieve real-time dynamic cytokine secretion
measurement. To address these limitations, the same research
group has recently applied DNA and RNA-based aptamers as
an alternative to antibodies and immobilized aptamers on an
array of micropatterned gold electrodes (Zhu et al., 2009; Liu
et al., 2012). The aptamers have been thiolated for assembly on
gold and functionalized with a methylene blue redox reporter
for electrochemical signal transduction and detection with gold
electrodes. Instead of using fluorescence-based biosensing meth-
ods, the authors have successfully demonstrated electrochemical
measurements to access dynamic cytokine secretion from human
monocytes and T-cells with a detection sensitivity of ∼ng/mL
(Zhu et al., 2009; Liu et al., 2012).
In addition to antibody- and aptamer-based immunopheno-
typing methods for subpopulations of immune cells, Chen et al.
(2013) have recently developed an integrated microfluidic device
employing a combined use of the PMM and antibody-conjugated
polystyrene microbeads for isolation, purification, and functional
immunophenotyping of subpopulation of immune cells directly
from unprocessed blood specimens (Figure 2D). In their method,
Chen et al. have first applied functionalized microbeads conju-
gated with monoclonal antibodies against specific cell surface pro-
teins to label and enlarge targeted subpopulations of immune cells
in blood specimens. After labeling using microbeads, blood speci-
men is introduced into the microfluidic device which contains the
PMM. The cell/microbead conjugates are readily trapped and iso-
lated on the PMM, whereas other untargeted blood cells unbound
to microbeads can freely pass through the PMM. Following cell
isolation, the AlphaLISA is applied for quantitative measurements
of cytokine secretion from LPS-stimulated immune cells captured
on the PMM.
MICROFLUIDICS TO STUDY FUNCTIONAL HETEROGENEITY
OF SINGLE IMMUNE CELLS
Functional and phenotypic variation among individual single
cells, or single-cell functional heterogeneity, is a common feature
for hematopoietic cells including immune cells. Thus, quantitative
functional analysis of immune cells down to a single-cell reso-
lution is required for a precise assessment of patient immune
status. Over the last decade, significant research efforts have
been directed toward applying microfluidics for manipulation
and functional analysis of single immune cells. One of the most
notable example entails plating and stimulating single immune
cells in an array of microfabricated wells, transferring soluble mol-
ecules secreted from immune cells onto a secondary solid surface
coated with capture antibodies, and labeling captured molecules
with fluorescently tagged proteins prior to subsequent optical
detection. For example, Love et al. (2006) have pioneered the
development of engraved microarrays made in PDMS using soft
lithography to monitor cytokines secreted from single immune
cells (Figure 2E). The engraved microarray consists of 25,000
microwells (50–100µm in diameter), each of which confines sin-
gle immune cells in a nanoliter volume. After individual immune
cells trapped and stimulated, the engraved microarray can be
flipped against an antigen- or secondary antibody-immobilized
glass slide to capture primary antibodies secreted from cells. Com-
pared to ELISpot, the engraved microarray enables a rapid (<12 h)
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and high-throughput (>10,000 individual cells) system for iden-
tification, recovery, and clonal expansion of single immune cells
producing antigen-specific antibodies. More recently, studies from
the same research group have demonstrated the capability of the
engraved microarray for characterization of dynamic cytokine
secretion from individual human T-cells after activation ex vivo
(Han et al., 2012; Varadarajan et al., 2012).
In addition to the microengraving method, Jin et al. (2009) have
recently independently developed a functional immunosensing
technique called “immunospot array assay on a chip” (or ISAAC)
to detect production of monoclonal antibodies by immune cells.
The ISAAC method offers a rapid and high-throughput system for
screening and analysis of antigen-specific antibody-secreting cells
(ASCs) on a single-cell basis. Similar to the microengraving assay,
the ISAAC also includes an array of microwells for trapping of sin-
gle live immune cells. The top surface of ISAAC is functionalized
with antibodies against immunoglobulin, and antibodies secreted
by individual ASCs trapped in the wells are captured and bound to
the device surface around the well. The ISAAC method is useful for
detecting ASCs in response to different antigens as well as for selec-
tion of ASCs secreting high-affinity antibodies. Although both the
microengraving and ISAAC methods have used a high-density
array of microwells to trap and isolate single immune cells, the
two methods utilize different detection techniques. Fundamen-
tally, the microengraving method pioneered by Love et al. (2006)
is based on ELISA, whereas the ISAAC is based on ELISpot (Jin
et al., 2009).
Ma et al. (2011) have recently applied the single-cell barcode
chip for high-content assessment of the functional heterogene-
ity of antigen-specific T-cells (Figure 2F). The single-cell barcode
chip consists of 1,040 microchambers with a nanoliter volume,
and each microchamber can trap single or a small number of
immune cells. On the bottom surface of each microchamber, a
spatially encoded antibody barcode array is pre-printed to capture
cytokines secreted from immune cells trapped in the microcham-
ber. Protein concentrations are measured with immunosandwich
assays from the spatially encoded antibody barcode. A full bar-
code from each microchamber represents a complete panel of
multiple cytokine species produced by a single immune cell (or a
few cells). The single-cell barcode chip permits highly multiplexed
(more than 10 proteins) on-chip detection of a few thousand pro-
teins or less from thousands of immune cells simultaneously. The
single-cell barcode chip reported by Ma et al. represents an excit-
ing and informative microfluidic single-cell immunophenotyping
tool for analyzing functional signatures of immune cells with high
sensitivity, throughput and multiplicity, and a small sample size
requirement.
All the microfluidic devices and systems discussed in this
section provide a promising potential for high-throughput study
of the functional heterogeneity of single immune cells. How-
ever, one critical issue common with these approaches is that
they require off-chip isolation and purification of target cells
from whole-blood prior to on-chip analysis. As such, there is
still an unmet need for a highly integrated microfluidic technol-
ogy platform for efficient isolation and informative systems-level
cellular characterization of immune cells down to the single-
cell level and using unprocessed or minimally processed blood
samples.
CONCLUSION
Developing reliable, multiplexed biosensing techniques that per-
mit simultaneous characterization of the functional status of
different subpopulations of immune cells at a single-cell reso-
lution is an exciting emerging concept. This concept holds a
great promise for unraveling pathogenesis as well as for translat-
ing newly available therapeutic options into optimal personalized
treatments. Continued progress in many fields ranging from fun-
damental immunology studies and clinical discoveries to patient
managements critically hinges on the availability of such immune
monitoring systems. Recent exciting developments in microfluidic
technology have provided promising tools for functional cellu-
lar immunophenotyping of blood specimens. These microflu-
idic immunophenotyping techniques can potentially provide an
unprecedented level of information depth on the distribution
of immune cell functionalities. We envision that such microflu-
idic immunophenotyping tools will allow comprehensive and
systems-level immunomonitoring in the future, thus unlocking
the potential to transform experimental clinical immunology into
an information-rich science.
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